Cabergoline in Practical Mammology

Высоцкая, И. В.; Депюи, Т. И.; Летягин, В. П.

doi:10.21518/2079-701x-2016-12-156-160

Med. sov.

2016

DOI: 10.21518/2079-701x-2016-12-156-160

|View full text |Cite

Cabergoline in Practical Mammology

И. В. Высоцкая¹,

Т. И. Депюи²,

В. П. Летягин³

Abstract: Патологическое повышение уровня пролактина-гиперпролактинемия-один из основных показателей дисфункции гипоталамо-гипофизарно-яичниковой системы. В результате этого ослабляется влияние дофамина на лактофоры, что приводит к их персистирующей гиперплазии и формированию функционально активных микро-и макроаденом с последующим еще большим повышением уровня пролактина. По статистическим данным, пролактиномы обнаруживаются у 25-30% женщин с патологической гиперпролактинемией.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 1 publication

(1 reference statement)

Supporting

Mentioning

Contrasting

Order By: Relevance

Mild hyperprolactinemia in clinical practice: the diagnostic “traps” and treatment strategy

Ilovayskaya,

Kruchinina

2024

Almanac of Clinical Medicine

View full text Add to dashboard Cite

Real world clinical practice frequently poses the question on the advisability of diagnostic and/or treatment interventions for increased prolactin levels of below 2500 mU/mL (100 ng/mL), which is commonly considered as mild and not unequivocally indicating a prolactinoma. The aim of the review is to critically analyze the body of literature within the last 10 years on clinical and biochemical particulars of patients with mildly increased prolactin levels. We performed the search in Pubmed and RISC (Russian Index of Science Citation) databases with the keywords of “mild hyperprolactinemia” and “women” (or their Russian equivalents). After exclusion of the studies in patients with primary hypothyroidism or treatment with agents inducing prolactin secretion, as well as of clinical case descriptions, we selected 21 original papers with clinical and biochemical data of female patients with mild hyperprolactinemia (prolactin levels of less than 2500 mU/mL or less than 100 ng/mL). Symptoms of mild hyperprolactinemia include menstrual cycle disorders, anovulatory infertility and/or early pregnancy losses, breast disorders, psychoemotional and sexual disorders, and metabolic abnormalities. Repeated testing of prolactin levels to exclude potential stress related to the vein puncture allows for exclusion of 27% to 28% of the patients from further diagnostic work up. Confirmation of persistently increased prolactin levels warrants a magnetic resonance imaging study of the pituitary. Most patients with persistently increased prolactin levels by repeated tests would have pituitary abnormalities (in most cases, pituitary microadenoma). Taking into account the data on negative effects of even mildly increased prolactin levels on reproductive and metabolic health, it is reasonable to administer a first line agent cabergoline at doses ensuring normoprolactinemia. The results of studies indicate that treatment with cabergoline at doses necessary to normalize prolactin levels would lead to regression of menstrual dysfunction, decrease the probability of early pregnancy losses, improve metabolic parameters, promotes restoration of the sexual function, and diminishes the level of depression. This is especially important when planning pregnancy in patients with menstrual cycle disorders, infertility and/or early pregnancy losses.

show abstract

Mild hyperprolactinemia in clinical practice: the diagnostic “traps” and treatment strategy

Ilovayskaya,

Kruchinina

2024

Almanac of Clinical Medicine

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Cabergoline in Practical Mammology

Cited by 1 publication

References 1 publication

Mild hyperprolactinemia in clinical practice: the diagnostic “traps” and treatment strategy

Mild hyperprolactinemia in clinical practice: the diagnostic “traps” and treatment strategy

Contact Info

Product

Resources

About